Literature DB >> 35578013

Correction to: Machine learning for rhabdomyosarcoma histopathology.

Arthur O Frankel1, Melvin Lathara2, Celine Y Shaw1, Owen Wogmon1, Jacob M Jackson1, Mattie M Clark1, Navah Eshraghi1, Stephanie E Keenen1, Andrew D Woods1, Reshma Purohit1, Yukitomo Ishi3, Nirupama Moran4, Mariko Eguchi5, Farhat Ul Ain Ahmed6, Sara Khan7, Maria Ioannou8, Konstantinos Perivoliotis9, Pin Li10, Huixia Zhou10, Ahmad Alkhaledi11, Elizabeth J Davis12, Danielle Galipeau13, R L Randall14, Agnieszka Wozniak15, Patrick Schoffski15, Che-Jui Lee15, Paul H Huang16, Robin L Jones16, Brian P Rubin17, Morgan Darrow18, Ganapati Srinivasa2, Erin R Rudzinski19, Sonja Chen20,21, Noah E Berlow22, Charles Keller23.   

Abstract

Entities:  

Year:  2022        PMID: 35578013     DOI: 10.1038/s41379-022-01098-4

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   8.209


× No keyword cloud information.
  1 in total

1.  How engineers and drug developers are working to change childhood cancer's deadly calculus.

Authors:  Esther Landhuis
Journal:  Nature       Date:  2022-06       Impact factor: 49.962

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.